@adamfeuerstein has generated 1,194 cashtag mentions across 161 distinct tickers in 929 posts over the past 12 months, with activity spanning biotech companies. The top five tickers by mention frequency are $SRPT (92 mentions), $IBRX (76 mentions), $QURE (52 mentions), $RVMD (49 mentions), and $ABVX (41 mentions). The account's most recent cashtag mention occurred on July 8, 2026.

Recent posts from @adamfeuerstein have focused on clinical and regulatory developments in the biotech space. On July 7, 2026, the voice posted about an FDA approval for Vera Therapeutics' kidney disease treatment, with mentions of both $VERA and the specific drug Trutakna for IgAN indication. The same day also included discussion of competitive positioning in the pancreatic cancer space, with commentary on how $ERAS might navigate the first-line PDAC market relative to $RVMD's head start, while questioning the reproducibility of Chinese data and addressing clinical equipoise arguments surrounding darox acceleration.